perylene has been researched along with HIV Coinfection in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmad, N; Bashyal, BP; Faeth, SH; Gunatilaka, AA; Ramakrishnan, R; Wellensiek, BP | 1 |
Crumpacker, C; Forcht, J; Gulick, RM; Holden-Wiltse, J; Hussey, S; Liebes, L; McAuliffe, V; Meehan, P; Stein, DS; Valentine, FT | 1 |
Kuhn, D | 1 |
1 trial(s) available for perylene and HIV Coinfection
Article | Year |
---|---|
Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258.
Topics: Administration, Oral; Adult; Anthracenes; Anti-HIV Agents; CD4 Lymphocyte Count; Dermatitis, Phototoxic; Female; Follow-Up Studies; HIV Core Protein p24; HIV Infections; Humans; Injections, Intravenous; Male; Perylene; RNA, Viral; Statistics, Nonparametric; Viral Load | 1999 |
2 other study(ies) available for perylene and HIV Coinfection
Article | Year |
---|---|
Altertoxins with potent anti-HIV activity from Alternaria tenuissima QUE1Se, a fungal endophyte of Quercus emoryi.
Topics: Alternaria; Anti-HIV Agents; Benz(a)Anthracenes; Endophytes; HIV Infections; HIV-1; Humans; Perylene; Quercus; T-Lymphocytes | 2014 |
Hypericin: an answer for safer blood?
Topics: Anthracenes; Antiviral Agents; Blood Preservation; Blood-Borne Pathogens; Clinical Trials as Topic; Cytomegalovirus; Hepatitis B; Hepatitis C; HIV; HIV Infections; Humans; Perylene; Sterilization | 1995 |